Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

The Diagnoses of Schizophrenia, Schizoaffective Disorder, Bipolar Disorder and Unipolar Depression: Interrater Reliability and Congruence between DSM-IV and ICD-10

Cheniaux E.a · Landeira-Fernandez J.b · Versiani M.c

Author affiliations

aInstitute of Psychiatry, Federal University of Rio de Janeiro (IPUB/UFRJ), and School of Medical Sciences, State University of Rio de Janeiro (FCM/UERJ), bPsychology Department, PUC-Rio, and Psychology Course, Estácio de Sá University, Campus Akxe, and cInstitute of Psychiatry, Federal University of Rio de Janeiro (IPUB/UFRJ), Rio de Janeiro, Brazil

Related Articles for ""

Psychopathology 2009;42:293–298

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: June 02, 2008
Accepted: December 01, 2008
Published online: July 16, 2009
Issue release date: August 2009

Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 3

ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)

For additional information: https://www.karger.com/PSP

Abstract

Background: The present study investigated the interrater reliability of the diagnoses of schizophrenia (SCH), schizoaffective disorder (SAD), bipolar disorder (BPD) and unipolar depression (UPD) according to both DSM-IV and ICD-10, as well as the diagnostic congruence between the two classificatory systems. Sampling and Methods: Using the Composite International Diagnostic Interview, two trained psychiatrists simultaneously evaluated 100 inpatients and independently assessed the psychiatric diagnoses. The Cohen’s kappa coefficient was employed to estimate interrater reliability and diagnostic congruence between DSM-IV and ICD-10. Results: SCH was more frequent according to ICD-10 than DSM-IV criteria. Considering both diagnostic systems, all the four nosological categories, but ICD-10 SAD and DSM-IV UPD, were associated with interrater reliability coefficients above 0.50. The coefficient of the diagnostic congruence between DSM-IV and ICD-10 was inferior to 0.50 only for SAD. BPD was associated with the highest degrees of both interrater reliability and diagnostic congruence. Conclusions: The lack of an item excluding the occurrence of an affective syndrome among ICD-10 diagnostic criteria for SCH can account for: the larger frequency of SCH according to ICD-10 than DSM-IV; the unsatisfactory interrater reliability for the diagnosis of ICD-10 SAD, and the low diagnostic congruence for SAD.

© 2009 S. Karger AG, Basel


References

  1. Akiskal HS: The classification of mental disorders; in Kaplan HI, Sadock BJ (eds): Comprehensive Textbook of Psychiatry, ed 5. Baltimore, Williams & Wilkins, 1989, vol 1, pp 583–598.
  2. Okasha A, Sadek A, al-Haddad MK, Abdel-Mawgoud M: Diagnostic agreement in psychiatry: a comparative study between ICD-9, ICD-10 and DSM-III-R. Br J Psychiatry 1993;162:621–626.
  3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, revised ed 3. Washington, American Psychiatric Association, 1987.
  4. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva, World Health Organization, 1993.
  5. Leboyer M, Maier W, Teherani M, Lichtermann D, D’Amato T, Franke P, Lepine JP, Minges J, McGuffin P: The reliability of the SADS-LA in a family study setting. Eur Arch Psychiatry Clin Neurosci 1991;241:165–169.
  6. Maj M, Pirozzi R, Formicola AM, Bartoli L, Bucci P: Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. J Affect Disord 2000;57:95–98.
  7. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T: Diagnostic interview for genetic studies: rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994;51:849–859.
  8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
  9. Williams JB, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Howes MJ, Kane J, Pope HG, Rounsaville B: The structured clinical interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry 1992;49:630–636.
  10. Cheniaux E, Landeira-Fernandez J, Lessa TL, Lessa JL, Dias A, Duncan T, Versiani M: Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. J Affect Disord 2008;106:209–217.
  11. Vollmer-Larsen A, Jacobsen TB, Hemmingsen R, Parnas J: Schizoaffective disorder – the reliability of its clinical diagnostic use. Acta Psychiatr Scand 2006;113:402–407.
  12. World Health Organization: CIDI-Auto (2.1) Administrator’s Guide and Reference. Sydney, World Health Organization, 1997.
  13. Cooper L, Peters L, Andrews G: Validity of the Composite International Diagnostic Interview (CIDI) psychosis module in a psychiatric setting. J Psychiatr Res 1998;32:361–368.
  14. Kessler RC, Akiskal HS, Angst J, Guyer M, Hirschfeld RM, Merikangas KR, Stang PE: Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J Affect Disord 2006;96:259–269.
  15. Wittchen HU: Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994;28:57–84.
  16. Landis JR, Koch GG: The measurements of observer agreement for categorical data. Biometrics 1977;33:159–174.
  17. Hiller W, Dichtl G, Hecht H, Hundt W, von Zerssen D: Testing the comparability of psychiatric diagnoses in ICD-10 and DSM-III-R. Psychopathology 1994;27:19–28.
  18. Wciorka J, Anczewska M, Bembenek A, Golebiewska M, Hochlewicz A, Nurowska K, Schaeffer E, Skowronska J, Stanikowska I, Tarczynska K: Psychopathological profile of acute schizophrenic syndromes diagnosed according to ICD-10 and DSM-IV criteria. Psychiatr Pol 1998;32:251–264.
  19. Armenteros JL, Fennelly BW, Hallin A, Adams PB, Pomerantz P, Michell M, Sanchez LE, Campbell M: Schizophrenia in hospitalized adolescents: clinical diagnosis, DSM-III-R, DSM-IV, and ICD-10 criteria. Psychopharmacol Bull 1995;31:383–387.
  20. Jakobsen KD, Frederiksen JN, Parnas J, Werge T: Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses. Psychopathology 2006;39:269–276.
  21. Mellsop GW, Thomas CS, Ellis PM, Purdie G, Crawshaw J, Mendis N: Reliability of the draft diagnostic criteria for research of ICD-10 in comparison with ICD-10 and DSM-III-R. Acta Psychiatr Scand 1991;84:332–335.
  22. Jansson LB, Parnas J: Competing definitions of schizophrenia: what can be learned from polydiagnostic studies? Schizophr Bull 2007;33:1178–1200.
  23. Del-Ben CM, Rodrigues CR, Zuardi AW: Reliability of the Portuguese version of the structured clinical interview for DSM-III-R (SCID) in a Brazilian sample of psychiatric outpatients. Braz J Med Biol Res 1996;29:1675–1682.
  24. Joo EJ, Joo YH, Hong JP, Hwang S, Maeng SJ, Han JH, Yang BH, Lee YS, Kim YS: Korean version of the diagnostic interview for genetic studies: validity and reliability. Compr Psychiatry 2004;45:225–229.
  25. Preisig M, Fenton BT, Matthey, ML, Berney A, Ferrero F: Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Eur Arch Psychiatry Clin Neurosci 1999;249:174–179.
  26. Quintana MI, Andreoli SB, Jorge MR, Gastal FL, Miranda CT: The reliability of the Brazilian version of the Composite International Diagnostic Interview (CIDI 2.1). Braz J Med Biol Res 2004;37:1739–1745.
  27. Rhi BY, Kwon JS, Lee C, Paik IH, Cho MJ, Lee ZN, Lee JH, Hahn KH, Kim JJ, Han SH: Reliability of the ICD-10 diagnostic criteria for research in mental disorders in the Republic of Korea. Acta Psychiatr Scand 1995;91:341–347.
  28. Roca M, Martin-Santos R, Saiz J, Obiols J, Serrano MJ, Torrens, M, Subirà S, Gili M, Navinés R, Ibañez A, Nadal M, Barrantes N, Cañellas F: Diagnostic Interview for Genetic Studies (DIGS): inter-rater and test-retest reliability and validity in a Spanish population. Eur Psychiatry 2007;22:44–48.
  29. Sartorius N, Ustun TB, Korten A, Cooper JE, van Drimmelen J: Progress toward achieving a common language in psychiatry. II. Results from the international field trials of the ICD-10 diagnostic criteria for research for mental and behavioral disorders. Am J Psychiatry 1995;152:1427–1437.
  30. Skre I, Onstad S, Torgersen S, Kringlen E: High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I). Acta Psychiatr Scand 1991;84:167–173.
  31. Otsubo T, Tanaka K, Koda R, Shinoda J, Sano N, Tanaka S, Aoyama H, Mimura M: Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psichiatry Clin Neurosci 2005;59:517–526.
  32. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22–33.
  33. Grove WM, Andreasen NC, McDonald-Scott P, Keller MB, Shapiro RW: Reliability studies of psychiatric diagnosis: theory and practice. Arch Gen Psychiatry 1981;38:408–413.
  34. Jager M, Bottlender R, Strauss A, Moller HJ: Classification of functional psychoses and its implication for prognosis: comparison between ICD-10 and DSM-IV. Psychopathology 2004;37:110–117.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: June 02, 2008
Accepted: December 01, 2008
Published online: July 16, 2009
Issue release date: August 2009

Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 3

ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)

For additional information: https://www.karger.com/PSP


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.